Marvel Biosciences Corp's total assets for Q4 2025 were C$326.71K, a decrease of -34.72% from the previous quarter. TSE:MRVL total liabilities were C$4.33M for the fiscal quarter, a 26.46% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.